Bray June
SEC insider (Form 3/4/5 filer). CIK 0001845487. Director at Quince Therapeutics, Inc. (QNCX) and 1 other issuer. 4 reported Form 4/5 transactions since Sep 2024; latest on Jan 9, 2026. Located in NEW HAVEN, CT.
Companies Bray June has filed insider reports for
- Quince Therapeutics, Inc. (QNCX): Director
- BioXcel Therapeutics, Inc. (BTAI): Director
Bray June
CIK: 0001845487
Transaction Breakdown
High conviction signal
Position reduction
Derivative conversions
Compensation grants
Gifts, tax withholding, conversions, dispositions to the issuer and other codes
Discretionary Trading P&L
Holdings
Transaction History (4 total)
- Jan 9, 2026BTAI
BioXcel Therapeutics, Inc.
AwardDirectStock Option (Right to Buy)
17K shares- - Jan 2, 2026QNCX
Quince Therapeutics, Inc.
AwardDirectDirector Stock Option (Right to Buy)
18.7K shares- - Jun 4, 2025QNCX
Quince Therapeutics, Inc.
AwardDirectDirector Stock Option (Right to Buy)
27K shares- - Jan 2, 2025QNCX
Quince Therapeutics, Inc.
AwardDirectDirector Stock Option (right to buy)
30.3K shares-
| Type | Shares | Price | Ownership | |||
|---|---|---|---|---|---|---|
| Jan 9, 2026 |  BTAI BioXcel Therapeutics, Inc. | Award Stock Option (Right to Buy) | 17,000 | - | - | Direct |
| Jan 2, 2026 |  QNCX Quince Therapeutics, Inc. | Award Director Stock Option (Right to Buy) | 18,724 | - | - | Direct |
| Jun 4, 2025 | QNCX Quince Therapeutics, Inc. | Award Director Stock Option (Right to Buy) | 27,000 | - | - | Direct |
| Jan 2, 2025 | QNCX Quince Therapeutics, Inc. | Award Director Stock Option (right to buy) | 30,282 | - | - | Direct |
1-4 of 4 transactions